Literature DB >> 32778

Tardive dyskinesia and antiparkinsonian medication.

G Chouinard, C De Montigny, L Annable.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 32778     DOI: 10.1176/ajp.136.2.228

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  6 in total

1.  Tardive dyskinesia in a nonpsychiatric patient due to short-term use of a neuroleptic/anticholinergic combination drug.

Authors:  G Chouinard; D Boisvert; J Bradwejn
Journal:  Can Med Assoc J       Date:  1982-04-01       Impact factor: 8.262

2.  Ineffectiveness of deanol in tardive dyskinesia: a placebo controlled study.

Authors:  C de Montigny; G Chouinard; L Annable
Journal:  Psychopharmacology (Berl)       Date:  1979-11       Impact factor: 4.530

Review 3.  Management of tardive dyskinesia: current update.

Authors:  G M Simpson; E H Pi; J J Sramek
Journal:  Drugs       Date:  1982-05       Impact factor: 9.546

4.  Effects of discontinuing anticholinergic treatment on movement disorders, cognition and psychopathology in patients with schizophrenia.

Authors:  Julie Eve Desmarais; Linda Beauclair; Lawrence Annable; Marie-Claire Bélanger; Theodore T Kolivakis; Howard C Margolese
Journal:  Ther Adv Psychopharmacol       Date:  2014-12

5.  Treatment of tardive dyskinesia with choline and tetrabenazine.

Authors:  A P Snell; M Cleary; M Sambrook
Journal:  Postgrad Med J       Date:  1980-09       Impact factor: 2.401

6.  Pimozide in the treatment of newly admitted schizophrenic patients.

Authors:  G Chouinard; L Annable
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.